National Defence Défense nationale
National Defence Headquarters Quartier général de la Défense nationale Ottawa, Ontario Ottawa (Ontario) K1A 0K2 K1A 0K2
CAN UNCLASSIFIED
The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic
Heather McCuaig Edge Department of National Defence
Canadian Forces Health Services Group HQ & Director General Military Personnel Research and Analysis
Samantha Carlucci ; Diane Lu Canadian Forces Health Services Group HQ
Canada Communicable Disease Report Volume 46, Number 9, 2020, pp.279-281
Date of Publication from Ext Publisher: September 2020
The body of this CAN UNCLASSIFIED document does not contain the required security banners according to DND security standards. However, it must be treated as CAN UNCLASSIFIED and protected appropriately based on the terms and conditions specified on the covering page.
Defence Research and Development Canada External Literature (N) DRDC-RDDC-2020-N175 October 2020
CAN UNCLASSIFIED
CAN UNCLASSIFIED
IMPORTANT INFORMATIVE STATEMENTS
This document was reviewed for Controlled Goods by Defence Research and Development Canada using the Schedule to the Defence Production Act.
Disclaimer: This document is not published by the Editorial Office of Defence Research and Development Canada, an agency of the Department of National Defence of Canada but is to be catalogued in the Canadian Defence Information System (CANDIS), the national repository for Defence S&T documents. Her Majesty the Queen in Right of Canada (Department of National Defence) makes no representations or warranties, expressed or implied, of any kind whatsoever, and assumes no liability for the accuracy, reliability, completeness, currency or usefulness of any information, product, process or material included in this document. Nothing in this document should be interpreted as an endorsement for the specific use of any tool, technique or process examined in it. Any reliance on, or use of, any information, product, process or material included in this document is at the sole risk of the person so using it or relying on it. Canada does not assume any liability in respect of any damages or losses arising out of or in connection with the use of, or reliance on, any information, product, process or material included in this document.
Template in use: EO Publishing App for CR-EL Eng 2019-01-03-v1.dotm
© Her Majesty the Queen in Right of Canada (Department of National Defence), 2020 © Sa Majesté la Reine en droit du Canada (Ministère de la Défense nationale), 2020
CAN UNCLASSIFIED , 2 1, ,21
H UROH RI RUFH HDO UR HF LR L H D D LD UPH RUFHV UHVSR VH R H 29, SD HPLF
HD HU F DL H DPD D DUO FFL LD H
LV R N LV OLFHQVHG QGH D & HDWL H &RPPRQV WW LE WLRQ ,QWH QDWLRQDO /LFHQVH
:LW LQ W H &DQDGLDQ PHG )R FHV & ) S EOLF HDOW LV PDQDJHG E W H L HFWR DWH RI )R FH HDOW 3 RWHFWLRQ ) 3 D E DQF RI W H &DQDGLDQ )R FHV HDOW 6H LFHV R S 6LQFH W H HPH JHQFH RI W H QR HO FR RQD L V 6 56 &R9 ) 3 DV EHFRPH HD LO Af liations LQ RO HG LQ HDOW V HLOODQFH R WE HDN PRQLWR LQJ SROLF GH HORSPHQW S R LGLQJ H LGHQFH EDVHG J LGDQFH DQG DG LFH OLDLVLQJ LW RW H QDWLRQDO S R LQFLDO WH LWR LDO P QLFLSDO DQG L HF R D H )R FH HDO LQWH QDWLRQDO S EOLF HDOW DJHQFLHV DQG HQV LQJ HQ L RQPHQWDO VDIHW RI & ) PHPEH V R HF LR D D LD )R FHV Some speci c activities include supporting operations and deployments, amending policies HDO 6H LFHV 2 D D 21 DQG W DLQLQJ DQG S RPRWLQJ DQG JLHQH S VLFDO GLVWDQFLQJ DQG SH VRQDO S RWHFWL H L HF R D H 5HVHD F H VR HO HT LSPHQW VH ,Q DGGLWLRQ WR WDNLQJ PHDV HV WR S RWHFW LWV PHPEH V & ) HSD WPHQW RI D )DPLO 6 SSR HSD PH RI 1D LR DO HIH FH 2 D D 21 1DWLRQDO HIHQFH DV FRQW LE WHG WR &DQDGD V QDWLRQDO HVSRQVH WR FR RQD L V GLVHDVH &29, H ) 3 LOO EH GH HORSLQJ W DLQLQJ IR DOOLHG HDOW S RIHVVLRQDOV WR DVVLVW LW FRQWDFW W DFLQJ DQG IROOR S DQG LOO HQV H DGHT DWH HVR FHV D H LQ SODFH WR PDQDJH V JH FDSDFLW IR &29, :LW W HVH RQJRLQJ HIIR WV LQLWLDWL HV DQG OHVVRQV OHD QHG ) 3 LV HOO Correspondence: SODFHG WR FD RQ LW LWV PDQGDWH WR S RWHFW DQG S RPRWH W H HDOW DQG HOO EHLQJ RI & ) HD H PFF DLJH JH IR FHV PHPEH V DQG 1DWLRQDO HIHQFH FL LOLDQ HPSOR HHV DVVLVWLQJ &DQDGLDQV DQG HQV LQJ W DW & ) JF FD PHPEH V D H HDG WR VH H W HL PLVVLRQV DW RPH DQG DE RDG
0F DLJ ( JH - D O FFL 6 / 7 H ROH RI )R FH HDO R HF LR L H D D LD PH )R FHV HVSR VH R H 29, SD HPLF D RPP LV 5HS SV RL R J FF L D 29, L HF R D H RI )R FH HDO R HF LR HSD PH RI 1D LR DO HIH FH SD HPLF HVSR VH FR R D L V V HLOOD FH D D LD PH )R FHV S EOLF HDO PLOL D Introduction Role of Force Health Protection in the Canadian Armed Forces’ response to ,Q HFHPEH D QR HO FR RQD L V HPH JHG LQ : DQ & LQD FD VLQJ DQ R WE HDN RI W H LQIHFWLR V GLVHDVH FR RQD L V coronavirus disease 2019 GLVHDVH &29, LF DV VLQFH EHFRPH D LGHVS HDG JOREDO SDQGHPLF 3 EOLF HDOW DJHQFLHV D R QG W H ) 3 LV HVSRQVLEOH IR S RPRWLQJ W H HOO EHLQJ RI PLOLWD R OG DQG LW LQ &DQDGD D H EHHQ DFWL HO PRQLWR LQJ DQG PHPEH V DQG IR HSLGHPLRORJLFDO V HLOODQFH FRPP QLFDEOH HVSRQGLQJ WR W H QHHGV RI W HL HVSHFWL H M LVGLFWLRQV H GLVHDVH FRQW RO DQG S H HQWLRQ HDOW S RPRWLRQ DQG HVSRQVLELOLW RI S RPRWLQJ S EOLF HDOW LW LQ W H &DQDGLDQ RFF SDWLRQDO DQG HQ L RQPHQWDO HDOW V V F G LQJ W H PHG )R FHV & ) LV PDQDJHG DQG PDLQWDLQHG E W H &29, R WE HDN ) 3 EHFDPH HD LO LQ RO HG LQ HDOW L HFWR DWH RI )R FH HDOW 3 RWHFWLRQ ) 3 D E DQF RI W H V HLOODQFH R WE HDN PRQLWR LQJ SROLF GH HORSPHQW S R LGLQJ &DQDGLDQ )R FHV HDOW 6H LFHV R S H LGHQFH EDVHG J LGDQFH DQG DG LFH OLDLVLQJ LW RW H QDWLRQDO S R LQFLDO DQG WH LWR LDO P QLFLSDO DQG LQWH QDWLRQDO S EOLF HDOW DJHQFLHV DQG HQV LQJ W H HQ L RQPHQWDO VDIHW RI & ) PHPEH V DQG HSD WPHQW RI 1DWLRQDO HIHQFH 1 VWDII PHPEH V
&& 5 6HSWHPEH 9RO 1R DJH , 2 1, ,21
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orld Health Organization has identi ed tobacco smoking as a SDQGHPLF RQ & ) D H R WOLQHG DV IROOR V LVN IDFWR IR &29, DQG VPRNLQJ DV EHHQ S HV PHG WR ,QF HDVLQJ W H PRQLWR LQJ DQG V HLOODQFH RI & ) PHPEH V EH DVVRFLDWHG LW DG H VH GLVHDVH S RJQRVLV ,Q HVSRQVH R NLQJ DE RDG IR W RVH GHSOR HG RQ RSH DWLRQV DQG DW F DV SD WQH HG LW GHQWDO DQG RPH S D PDF DPRQJ RW H SD WQH V LW LQ &DQDGLDQ )R FHV HDOW DNLQJ PHDV HV WR DGM VW RSH DWLRQV V F DV GHOD LQJ 6H LFHV WR DFWL HO S RPRWH VPRNLQJ FHVVDWLRQ WR HG FH D P GHSOR PHQWV DPHQGLQJ W H Q PEH RI SH VRQQHO R D H WR VPRNH V G LQJ W H SDQGHPLF F DV GHSOR HG DQG PRGLI LQJ W H OHQJW RI GHSOR PHQWV WR DOVR EHHQ LQ RO HG LQ W H LPSOHPHQWDWLRQ RI D FRQWDFW W DFLQJ HQV H SH VRQQHO D H S RWHFWHG LOH FRQWLQ LQJ WR SH IR P V JH FDSDELOLW IR & ) PHPEH V H 2FF SDWLRQDO DQG F LWLFDO WDVNV (Q L RQPHQWDO HDOW VHFWLRQ DV EHHQ FRQWLQ R VO PRQLWR LQJ 3 RPRWLQJ JRRG DQG JLHQH DQG S VLFDO GLVWDQFLQJ W H SDQGHPLF DQG DGM VWLQJ PHDV HV WR S RWHFW & ) PHPEH V HQH H SRVVLEOH DQG GRQQLQJ DSS RS LDWH SH VRQDO DQG 1 HPSOR HHV DFFR GLQJO HVH FRQW RO PHDV HV FRQVLVW S RWHFWL H HT LSPHQW 33( RI S R LGLQJ DG LFH DQG J LGDQFH RQ IHDVLEOH DQG HIIHFWL H 5HG FLQJ FRQWDFW E LPSRVLQJ D GD T D DQWLQH EHIR H HQJLQHH LQJ FRQW ROV L H S RSH RSH DWLRQ RI E LOGLQJ HQWLODWLRQ DQG DIWH GHSOR PHQWV RQ RSH DWLRQV LW W H 5R DO V VWHPV VDIHJ D GLQJ G LQNLQJ DWH SRWDELOLW DGPLQLVW DWL H &DQDGLDQ 1D WHVWLQJ VHT HVWH HG LQGL LG DOV S LR WR FRQW ROV L H SH VRQDO JLHQH PHDV HV DQG RQ W H VH RI 33( ERD GLQJ W H V LS (i.e. t testing, medical grade versus industrial respirators, N95 5HT L LQJ SH VRQQHO WR GLVFORVH W HL SRWHQWLDO H SRV H HS RFHVVLQJ DQG W H VH RI H SL HG HVSL DWR V ,Q DGGLWLRQ WR &29, DQG WR VHHN PHGLFDO FD H S RPSWO LI W H 2FF SDWLRQDO DQG (Q L RQPHQWDO HDOW DV EHHQ S R LGLQJ develop u-like symptoms within 14 days of travel or have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guidance on CAF-speci c public health measures and policies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were in uenced by the advice and direction from DFHP. Each S R LQFLDO ODER DWR LHV &OLQLFDO HQFR QWH V LW &DQDGLDQ )R FHV VHFWLRQ LW LQ ) 3 DV EHHQ HD LO LQ RO HG LQ DQG FRQW LE WHG HDOW 6H LFHV FOLQLFV D H FDSW HG E ) 3 LW LQLWLDWLRQ RI WR GLIIH HQW DVSHFWV RI & ) 1 &29, HVSRQVH H DSS RS LDWH IROOR S DQG FRQWDFW W DFLQJ R H H V HLOODQFH (SLGHPLRORJ VHFWLRQ DV S R LGHG V HLOODQFH DQG PRQLWR LQJ DQG PRQLWR LQJ IR DOO & ) SH VRQQHO LV FRPSOH EHFD VH RI 5HJ OD DQG 5HVH H )R FH & ) PHPEH V IR &29, WHVWLQJ DQG FRQWDFW W DFLQJ LV LQWH W LQHG EHW HHQ W H PLOLWD HVSHFLDOO JL HQ GHSOR PHQWV WR ORQJ WH P FD H IDFLOLWLHV LW LQ DQG FL LOLDQ VHFWR V ORFDO S R LQFLDO S EOLF HDOW D W R LWLHV
3DJH && 5 6HSWHPEH 9RO 1R , 2 1, ,21
GGLQJ WR W LV FRPSOH LW D H W H HJLRQDO GLIIH HQFHV DPRQJ W H Acknowledgments EDVHV LQJV DF RVV & ) G H WR S R LQFLDO WH LWR LDO GLIIH HQFHV in reporting con rmed cases, contact tracing, developing H D W R V R OG OLNH WR W DQN W H PHPEH V RI W H &DQDGLDQ SROLFLHV D R QG S EOLF HDOW PHDV HV DQG GHFOD LQJ VWDWHV RI )R FHV HDOW 6H LFHV R S DQG W H L HFWR DWH RI )R FH HPH JHQFLHV ) 3 DV EHHQ WDVNHG E W H HS W 6 JHRQ HDOW 3 RWHFWLRQ PHPEH V RI W H &DQDGLDQ PHG )R FHV HQH DO LW GH HORSLQJ D W DLQLQJ S RJ DP IR DOOLHG HDOW DQG DOO RI W H FL LOLDQ DQG PLOLWD I RQW OLQH R NH V IR S RIHVVLRQDOV WR FRQG FW FRQWDFW W DFLQJ WR HVSRQG WR SRVVLEOH FRQW LE WLQJ WR W H SDQGHPLF HVSRQVH W DQN R DV HOO WR V JH FDSDFLW DQG FO VWH R WE HDNV RI &29, Col P Morissette, Cdr K Barnes, LCol S Blier, Dr. M Carew and 0 DGV D IR H LH LQJ W LV HSR W V W H VLW DWLRQ QR PDOL HV DQG SHRSOH HW Q WR R N D WRS S LR LW IR 1 LV W H HDOW RI LWV & ) SH VRQQHO H ) 3 LV DFWL HO HQJDJHG LQ S R LGLQJ DG LFH WR & ) OHDGH V LS Funding HJD GLQJ E VLQHVV HV PSWLRQ DFWL LWLHV LOO FRQWLQ H WR follow the epidemiological situation and scienti c evidence LV R N DV V SSR WHG E W H HSD WPHQW RI 1DWLRQDO FORVHO LQ R GH WR HOS PDNH H LGHQFH EDVHG HFRPPHQGDWLRQV HIHQFH &DQDGD RQ S EOLF HDOW S H HQWL H PHDV HV DQG LOO FRQWLQ H WR S R LGH J LGDQFH DQG H LVH SROLFLHV DV W H VLW DWLRQ H RO HV References
Ensuring better emergency :R OG HDOW 2 JDQL DWLRQ 4 RQ FR RQD L VHV &29, HQH D & : 2 DFFHVVHG preparedness in the future WWSV R LQW HPH JHQFLHV GLVHDVHV QR HO FR RQD L V T HVWLRQ DQG DQV H V E T D R J R W W LV SDQGHPLF 1 DV EHHQ PDGH D D H RI GHWDLO T D FR RQD L VHV RSH DWLRQDO OLPLWDWLRQV 6RPH RI W H D V W DW ) 3 LV H SOR LQJ WR HQV H EHWWH HPH JHQF S HSD HGQHVV LQ W H I W H D H R H QPHQW RI &DQDGD 0LOLWD HVSRQVH WR &29, GHVF LEHG DV IROOR V R H QPHQW RI &DQDGD DFFHVVHG Increase staf ng resources, including ensuring that there is WWSV FDQDGD FD HQ GHSD WPHQW QDWLRQDO GHIHQFH FDPSDLJQV FR LG PLOLWD HVSRQVH WPO WPB D V SO V RI HDGLO GHSOR DEOH W DLQHG VWDII H J 3 H HQWL H VR FH FR LG FDPSDLJQ WPBPHGL P HDGLQJ WPB 0HGLFLQH HF QLFLDQV FDPSDLJQ FR LG ,PS R H FRPP QLFDWLRQ FROODER DWLRQ DQG FRR GLQDWLRQ RI HIIR WV EHW HHQ W H PLOLWD DQG FL LOLDQ VHFWR V 1DWLRQDO HIHQFH & DQJHV WR PLOLWD RSH DWLRQV LQ ,PS R H V HLOODQFH FDSDFLW HVSRQVH WR &29, 1 DFFHVVHG 0DQDJH HVR FHV H J 33( DV HOO DV H SHFWDWLRQV RI WWSV FDQDGD FD HQ GHSD WPHQW QDWLRQDO GHIHQFH VH LFHV RSH DWLRQV PLOLWD RSH DWLRQV FR LG WPO VHQLR OHDGH V LS & DLQ RI &RPPDQG 1DWLRQDO HIHQFH 2SH DWLRQ / 6(5 1 :LW DGHT DWH V SSR W WR W HVH RQJRLQJ HIIR WV LQLWLDWL HV DFFHVVHG WWSV FDQDGD FD HQ DQG OHVVRQV OHD QHG ) 3 LV HOO SODFHG WR FD RQ LW LWV GHSD WPHQW QDWLRQDO GHIHQFH VH LFHV RSH DWLRQV PDQGDWH WR S RWHFW DQG S RPRWH W H HDOW DQG HOO EHLQJ RI PLOLWD RSH DWLRQV F HQW RSH DWLRQV ODVH WPO & ) PHPEH V DQG WR HQV H W DW PHPEH V D H HDG WR VH H World Health Organization (Region Of ce for the Eastern RQ W HL PLVVLRQV ERW DW RPH DQG DE RDG 0HGLWH DQHDQ REDFFR ) HH LQLWLDWL H REDFFR DQG DWH SLSH VH LQF HDVHV W H LVN RI &29, &DL R (J SW : 2 DFFHVVHG HP R R Authors’ statement int/t /NQR W H W W WREDFFR DQG DWH SLSH VH V D H DW LQF HDVHG LVN RI FR LG LQIHFWLRQ WPO -0( 6& DQG / H H DOO LQ RO HG LQ W H FRQFHSW DOL DWLRQ Vardavas CI, Nikitara K. COVID-19 and smoking: A G DIWLQJ DQG H LVLQJ RI W H SDSH V VWHPDWLF H LH RI W H H LGHQFH RE ,QG F LV 0D F 2, 3 E0HG Competing interests 1RQH
&& 5 6HSWHPEH 9RO 1R DJH
DOCUMENT CONTROL DATA *Security markings for the title, authors, abstract and keywords must be entered when the document is sensitive 1. ORIGINATOR (Name and address of the organization preparing the document. 2 a . SECURITY MARKING A DRDC Centre sponsoring a contractor's report, or tasking agency, is entered (Overall security marking of the document including in Section 8.) special supplemental markings if applicable.)
Canada Communicable Disease Report CAN UNCLASSIFIED Public Health Agency of Canada 130 Colonnade Road Address Locator 6503A 2b. CONTROLLED GOODS Ottawa, Ontario K1A 0K9 NON-CONTROLLED GOODS Canada DMC A
3. TITLE (The document title and sub-title as indicated on the title page.)
The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic
4. AUTHORS (Last name, followed by initials – ranks, titles, etc., not to be used) Edge, H. M.; Carlucci, S.; Lu, D.
5. DATE OF PUBLICATION 6a. NO. OF PAGES 6b. NO. OF REFS (Month and year of publication of document.) (Total pages, including (Total references cited.) Annexes, excluding DCD, covering and verso pages.) September 2020 3 6
7. DOCUMENT CATEGORY (e.g., Scientific Report, Contract Report, Scientific Letter.)
External Literature (N)
8. SPONSORING CENTRE (The name and address of the department project office or laboratory sponsoring the research and development.)
DGMPRA Director General Military Personnel Research and Analysis NDHQ (Carling), 60 Moodie Drive, Building 9S.2 Ottawa, Ontario K1A 0K2 Canada
9a. PROJECT OR GRANT NO. (If appropriate, the applicable 9b. CONTRACT NO. (If appropriate, the applicable number under research and development project or grant number under which which the document was written.) the document was written. Please specify whether project or grant.)
04k
10a. DRDC PUBLICATION NUMBER (The official document number 10b. OTHER DOCUMENT NO(s). (Any other numbers which may be by which the document is identified by the originating assigned this document either by the originator or by the sponsor.) activity. This number must be unique to this document.)
DRDC-RDDC-2020-N175
11a. FUTURE DISTRIBUTION WITHIN CANADA (Approval for further dissemination of the document. Security classification must also be considered.)
Public release
11b. FUTURE DISTRIBUTION OUTSIDE CANADA (Approval for further dissemination of the document. Security classification must also be considered.)
NONE
12. KEYWORDS, DESCRIPTORS or IDENTIFIERS (Use semi-colon as a delimiter.)
COVID-19 ; Directorate of Force Health Protection; Department of National Defence ; pandemic; Coronavirus; air surveillance radar; surveillance; Canadian Armed Forces; military
13. ABSTRACT/RÉSUMÉ (When available in the document, the French version of the abstract must be included here.)
Within the Canadian Armed Forces (CAF), public health is managed by the Directorate of Force Health Protection (DFHP), a branch of the Canadian Forces Health Services Group. Since the emergence of the novel coronavirus (SARS-CoV-19), DFHP has become heavily involved in health surveillance, outbreak monitoring, policy development, providing evidencebased guidance and advice, liaising with other national, provincial/territorial, municipal and international public health agencies, and ensuring environmental safety of CAF members. Some specific activities include supporting operations and deployments, amending policies and training and promoting hand hygiene, physical distancing and personal protective equipment use. In addition to taking measures to protect its members, CAF-Department of National Defence has contributed to Canada’s national response to coronavirus disease 2019 (COVID-19). The DFHP will be developing training for allied health professionals to assist with contact tracing and follow-up, and will ensure adequate resources are in place to manage surge capacity for COVID-19. With these ongoing efforts, initiatives and lessons learned, DFHP is well placed to carry on with its mandate to protect and promote the health and well-being of CAF members and National Defence civilian employees, assisting Canadians and ensuring that CAF members are ready to serve their missions at home and abroad.